Exploring leukemia prognosis in Shiny

A Shiny app to explore the relationship between patient prognosis and gene expression.


Galaxy@SLU provides free and easy-to-use bioinformatics tools for analyzing ChIP-Seq, RNA-Seq, scRNA-Seq, and other high-throughput datasets.

Mechanism of Disease Progression In AML

ETO2/MTG16/CBFA2T3, a scaffold transcriptional corepressor, drives relapse and determines patient-specific outcome in AML.

Drug Resistance In AML

TBLR1 controls retinoic acid responsiveness in AML.